Sunpointe, LLC Xeris Biopharma Holdings, Inc. Transaction History
Sunpointe, LLC
- $199 Billion
- Q4 2024
A detailed history of Sunpointe, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Sunpointe, LLC holds 21,000 shares of XERS stock, worth $75,390. This represents 0.04% of its overall portfolio holdings.
Number of Shares
21,000Holding current value
$75,390% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
60.2MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$27.9 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$18.4 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$12.5 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$12 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $488M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...